Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,532 Jan 1 – Oct 27, 2026
- Disclosed funding
- $64.3B 1240 disclosed amounts
- Median round
- $6.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
MCatalysisCompany profile MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. | $5M | Seed | Climate tech | United Kingdom | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors | |
CloudNCCompany profile CloudNC builds AI software for precision machining, helping machine shops develop CNC programs and quotes faster while keeping machinists in control of final decisions. CloudNC builds AI software for precision machining, helping machine shops develop CNC programs and quotes faster while keeping machinists in control of final decisions. | $20M | Series B extensionSeries B | Industrial tech | United Kingdom | Investors | |
Anemo LabsCompany profile Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. | £700K | Pre-seed | Healthtech | United Kingdom | Investors | |
ZeroRiskCompany profile A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. | $10M | Series A | Cybersecurity | Ireland | Investors | |
HelmGuardCompany profile An AI-powered security and compliance platform that connects company systems and policies, then uses agents to collect evidence, assess internal controls and vendors, and prepare auditable findings for human review. An AI-powered security and compliance platform that connects company systems and policies, then uses agents to collect evidence, assess internal controls and vendors, and prepare auditable findings for human review. | $7.3M | Seed | Cybersecurity | United Kingdom | Investors | |
FRYTE MobilityCompany profile An open software platform that links electric-truck route planning and logistics systems with charging networks so fleets can reserve compatible charging slots across providers. An open software platform that links electric-truck route planning and logistics systems with charging networks so fleets can reserve compatible charging slots across providers. | €3.5M | Seed | Mobility | Germany | Investors | |
AssaiaCompany profile Assaia uses computer vision and AI to give airports and airlines real-time visibility into aircraft turnarounds, gate use and apron operations. Assaia uses computer vision and AI to give airports and airlines real-time visibility into aircraft turnarounds, gate use and apron operations. | Undisclosed | Strategic investmentUndisclosed | AI | Switzerland | Investors | |
Neurent MedicalCompany profile Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. | $25M | Growth investmentGrowth | Healthtech | Ireland | Investors | |
FundcraftCompany profile Fundcraft combines software with regulated fund-administration and AIFM services for alternative-asset managers. Its platform and operating teams manage fund, investor and portfolio workflows—including onboarding, accounting, compliance and reporting—across jurisdictions. Fundcraft combines software with regulated fund-administration and AIFM services for alternative-asset managers. Its platform and operating teams manage fund, investor and portfolio workflows—including onboarding, accounting, compliance and reporting—across jurisdictions. | €12M | Growth financingGrowth | Fintech | Luxembourg | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
39rounds4led - 2Antler
Jenz, Affinity Labs, CodeWall
26rounds0led - 3Y Combinator (YC)
HyLight, Sensible Biotechnologies, Revnu
22rounds1led - 4General Catalyst
Legora, Complir, Integral
21rounds1led - 5Index Ventures
Opply, Duvo, Spiko
21rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.